Academic Journal of Business & Management, 2024, 6(9); doi: 10.25236/AJBM.2024.060939.
Wenyu Shi1, Tingting Wang2
1School of Economics and Management, Changsha Normal University, Changsha, 410000, China
2School of Economics and Management, Northeast Petroleum University, Daqing, 163000, China
In view of the increasingly prominent financial risks caused by the limited scale and insufficient innovation ability of the domestic pharmaceutical market, in order to explore how to effectively prevent financial risks and promote the stable development of pharmaceutical enterprises. This article takes Changjiang Health as an exampleand uses the Z-score model to analyze its financial risks in depth. It focuses on the impact of controlling shareholder violations on the company's financial health, comparesindustry performance, and reveals its financial vulnerability. After analysis, ChangjiangHealth is facing high financial risks and needs to optimize its capital and debt structure and strengthen financial control. Meanwhile, this study provides a reference for financial risk assessment in the pharmaceutical industry. The research results not only guide the Yangtze River Health to improve financial health, but also provide risk warnings for investors inside and outside the industry, better promoting the sustainable development of the pharmaceutical industry as a whole.
Pharmaceutical Industry, Z-score Model, Financial Risk Analysis, Debt Paying Ability, Profitability
Wenyu Shi, Tingting Wang. Financial Risk Analysis of the Pharmaceutical Industry Based on Z-score Model: A Case Study of Changjiang Health. Academic Journal of Business & Management (2024) Vol. 6, Issue 9: 285-292. https://doi.org/10.25236/AJBM.2024.060939.
[1] Guo Yue. Research on Financial Risk Identification, Assessment, and Response Strategies of Private Enterprises in PPP Model [D]. Inner Mongolia University of Finance and Economics, 2024
[2] Wang Fang. Research on Financial Risk Analysis and Control of Enterprise Mergers and Acquisitions [J]. Modern Marketing (Volume 1), 2024, (06): 79-81
[3] Yang Xuting. Research on Internal Control Risk Assessment of K University in Inner Mongolia [D]. Inner Mongolia University of Science and Technology, 2022
[4] Sun Xinyu, Yu Shanbo. Analysis and Prevention of Enterprise Financial Risks Based on Internal Control [J]. Modernization of Shopping Malls, 2020, (6): 143-144
[5] Shi Bin, Zhang Shuxin. Research on Financial Risk Analysis and Control of Pharmaceutical Enterprises - Taking Fosun Pharma as an Example [J]. Chinese Market, 2023, (30): 93-96
[6] Tong Linchen. Empirical study on the causes of reverse financing in technology-based enterprises [J]. China Business Review, 2021, (20): 118-121
[7] Su Hao, Cao Xueping. The major shareholder of Changjiang Health has been registered for occupying a huge amount of funds [N]. China Business News, May 13, 2024 (B14)
[8] Fang Xiaolong. Analysis of Enterprise Performance Evaluation Based on Debt Repayment Ability [J]. Finance and Economics, 2023, (33): 57-59
[9] Hui Yingxin. Analysis of Debt Repayment Ability of New Energy Enterprises and Countermeasures Suggestions - Taking Company A as an Example [J]. Hebei Enterprise, 2023, (08): 114-116
[10] Tan Yuan. Profitability Analysis of Listed Companies -- Taking the Coal Industry as an Example [J]. Journal of Mount Huangshan University, 2023,25 (05): 6-10